FDA Mandating Unique IDs for Medical Devices

The agency's rule will require most Class III devices, such as automated external defibrillators, to have unique device identifiers on their label and packaging within a year.

A Sept. 20 final rule published by the U.S. Food and Drug Administration will require manufacturers of medical devices to assign unique identifiers to them. The use of the Unique Device Identification system will give the agency and the industry a consistent way to identify medical devices throughout their distribution and eventual use.

"Most devices may be required to have a code on their label and packaging, and for certain devices, on the product itself, in plain text and a machine-readable format, like a bar code. This code will correspond to the specific model or version of a device and will include production information, such as the lot number and expiration date. It will also provide a link to a publicly available database – called the Global Unique Device Identification Database – where you can find information about some of the devices’ key characteristics, such as model and brand – but no identifying patient information will be stored there," Dr. Jeffrey Shuren, M.D., J.D., director of FDA's Center for Devices and Radiological Health, explained in a Sept. 20 post to an FDA blog. "FDA worked with the health care community and the device industry to develop a system that will provide a clear way of documenting device use in electronic health records and clinical information systems."

FDA published a proposed rule for this purpose in July 2012.

The UDI system consists of two core items: a unique number assigned by the device manufacturer to the version or model of a device, which includes production-specific information such as a lot or batch number, expiration date, and manufacturing date when that information appears on the label; and the database administered by FDA.

The agency is phasing in the UDI system. High-risk medical devices in Class III, which includes automated external defibrillators, heart valves, and artificial hips, will be required to have unique device identifiers on their label and packaging within a year. Manufacturers will have three years to act for most Class II (moderate risk) devices and five years for Class I devices. Some Class I devices will be exempt from UDI requirements completely, however.

Download Center

  • EHS Buyer's Guide

    Download this buyer's guide to make more informed decisions as you're looking for an EHS management software system for your organization.

  • Online Safety Training Buyer's Guide

    Use this handy buyer's guide to learn the basics of selecting online safety training and how to use it at your workplace.

  • COVID Return-to-Work Checklist, Fall 2021

    Use this checklist as an aid to help your organization return to work during the COVID-19 pandemic in a safe and healthy manner.

  • SDS Buyer's Guide

    Learn to make informed decisions while searching for SDS Management Software.

  • Risk Matrix Guide

    Risk matrices come in many different shapes and sizes. Understanding the components of a risk matrix will allow you and your organization to manage risk effectively.

  • Industry Safe

Featured Whitepapers

OH&S Digital Edition

  • OHS Magazine Digital Edition - September 2021

    September 2021

    Featuring:

    • COMBUSTIBLE DUST
      Managing Combustible Dust and Risk Mitigation
    • PPE: CONSTRUCTION
      The Rising Popularity of Safety Helmets on the Jobsite
    • PPE: ELECTRICAL SAFETY
      Five Tips for a Successful Wear Trial
    • SAFETY & HEALTH
      Medical Surveillance Versus Medical Screening
    View This Issue